Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

JNJ - Johnson & Johnson - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4781601046

Medicines, Medical Devices, Contact Lenses, Surgical Tools, Orthopedic Implants

Johnson & Johnson is a multinational healthcare company that researches, develops, manufactures, and sells a wide range of products worldwide. The company's Innovative Medicine segment is a key driver of its business, offering products that cater to various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Within its immunology portfolio, Johnson & Johnson offers treatments for conditions such as rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. Its infectious diseases segment includes products for HIV/AIDS, while its neuroscience portfolio focuses on mood disorders, neurodegenerative disorders, and schizophrenia. The company's oncology segment offers treatments for various types of cancer, including prostate cancer, hematologic malignancies, lung cancer, and bladder cancer. Additionally, its cardiovascular and metabolism segment provides products for thrombosis, diabetes, and macular degeneration, as well as treatments for pulmonary arterial hypertension.

Johnson & Johnson's MedTech segment is another significant contributor to its business, offering a range of medical devices and technologies. Its Interventional Solutions portfolio includes electrophysiology products for treating heart rhythm disorders, as well as technologies for treating severe coronary artery disease and cardiogenic shock. The company's neurovascular care portfolio offers solutions for hemorrhagic and ischemic stroke. Its orthopaedics portfolio includes products and enabling technologies for hips, knees, trauma, spine, sports, and other areas, while its surgery portfolios comprise advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures.

In addition to its medical devices, Johnson & Johnson's MedTech segment also offers contact lenses under the ACUVUE brand, as well as TECNIS intraocular lenses for cataract surgery. The company distributes its products to a wide range of customers, including wholesalers, hospitals, retailers, physicians, nurses, hospitals, eye care professionals, and clinics. With a rich history dating back to 1886, Johnson & Johnson is headquartered in New Brunswick, New Jersey, and is one of the largest and most respected healthcare companies in the world.

Today, Johnson & Johnson continues to innovate and expand its product portfolio, with a strong focus on research and development. The company's commitment to improving human health and well-being has made it a leader in the healthcare industry, with a presence in over 175 countries worldwide. Its website, https://www.jnj.com, provides more information on its products, services, and mission.

Drawdown (Underwater) Chart

Overall Trend and Yearly Seasonality

JNJ Stock Overview

Market Cap in USD	363,433m
Sector	Healthcare
Industry	Drug Manufacturers - General
GiC SubIndustry	Pharmaceuticals
TER	0.00%
IPO / Inception	1944-09-24

JNJ Stock Ratings

Growth 5y	30.2
Fundamental	76.1
Dividend	55.4
Rel. Performance vs Sector	-0.57
Analysts	3.83/5
Fair Price Momentum	154.01 USD
Fair Price DCF	204.88 USD

JNJ Dividends

Dividend Yield 12m	2.99%
Yield on Cost 5y	4.15%
Dividends CAGR 5y	4.62%
Payout Consistency	82.9%

JNJ Growth Ratios

Growth 12m	-5.05%
Growth Correlation 12m	-32%
Growth Correlation 3m	19%
CAGR 5y	6.72%
CAGR/Mean DD 5y	1.01
Sharpe Ratio 12m	-0.66
Alpha vs SP500 12m	-19.18
Beta vs SP500 5y weekly	0.57
ValueRay RSI	97.97
Volatility GJR Garch 1y	17.06%
Price / SMA 50	7.73%
Price / SMA 200	5.87%
Current Volume	8356.9k
Average Volume 20d	7043.1k

External Links for JNJ Stock

News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle

What is the price of JNJ stocks?
As of July 27, 2024, the stock is trading at USD 160.64 with a total of 8,356,878 shares traded.
Over the past week, the price has changed by +3.85%, over one month by +9.41%, over three months by +10.81% and over the past year by -1.11%.

What are the forecast for JNJ stock price target?
According to ValueRays Forecast Model, JNJ Johnson & Johnson will be worth about 168.8 in July 2025. The stock is currently trading at 160.64. This means that the stock has a potential upside of +5.09%.

Issuer	Forecast	Upside
Wallstreet Target Price	171.7	6.90
Analysts Target Price	168.5	4.87
ValueRay Target Price	168.8	5.09

Johnson & Johnson: Navigating Through History to Modern Success

History at a Glance

Johnson & Johnson (J&J), founded in 1886 by three Johnson brothers, Robert, James, and Edward, began its journey with the aim of producing sterile surgical supplies. This innovation marked the start of a company that would grow to become a cornerstone in the healthcare industry, paving the way with its commitment to improving health for people worldwide.

Core Businesses

J&J has strategically branched out into three main sectors over the years: Pharmaceuticals, Medical Devices, and Consumer Health Products. The Pharmaceuticals division focuses on researching and developing medications for various diseases. The Medical Devices sector offers a wide range of health care products used by professionals. Lastly, the Consumer Health Products division brings everyday health and personal care products to consumers worldwide.

Side Businesses and Diversification

Beyond its primary operations, J&J has also ventured into areas such as digital health solutions and acquisitions that complement its core businesses. This diversification not only expands J&J’s portfolio but also strengthens its position in the healthcare market by meeting a broader range of consumer and medical needs.

Current Market Status

As of today, Johnson & Johnson stands as a giant in the healthcare field, with a strong presence on the New York Stock Exchange (NYSE: JNJ). Despite the complexities and competitive nature of the healthcare industry, J&J has demonstrated resilience and growth. Its commitment to innovation, research, and development continues to drive the company forward, ensuring its place as a leader in providing healthcare solutions.